Growth inhibition of RAS-mutated hematopoietic tumor cells using glucose-attached reversibly ionic oligonucleotide-based nanoparticles caging chemically modified microRNA143-3p-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Growth inhibition of RAS-mutated hematopoietic tumor cells using glucose-attached reversibly ionic oligonucleotide-based nanoparticles caging chemically modified microRNA143-3p

Published:2023-10 Issue: Volume:88 Page:104902
ISSN:1773-2247
Container-title:Journal of Drug Delivery Science and Technology
language:en
Short-container-title:Journal of Drug Delivery Science and Technology

Author:

Miyamoto Noriko^ORCID,Sugito Nobuhiko^ORCID,Kitade Yukio,Akao Yukihiro^ORCID

Funder

University of Kitakyushu

Ministry of Education, Culture, Sports, Science and Technology

Huaihai Institute of Technology

Japan Science and Technology Agency

ACT-X

Gifu University

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference22 articles.

1. High-efficiency transfection of suspension cell lines;Basiouni;Biotechniques,2012

2. The origins and genetic interactions of KRAS mutations are allele- and tissue-specific;Cook;Nat. Commun.,2021

3. Impairment of K-Ras signaling networks and increased efficacy of epidermal growth factor receptor inhibitors by a novel synthetic miR-143;Akao;Cancer Sci.,2018

4. MicroRNA-143/Musashi-2/KRAS cascade contributes positively to carcinogenesis in human bladder cancer;Tsujino;Cancer Sci.,2019

5. Chemically modified MIR143-3p exhibited anti-cancer effects by impairing the KRAS network in colorectal cancer cells;Sugito;Mol. Ther. Nucleic Acids,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP